List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 543 studies with search of: Peginterferon alfa-2 OR "Pegasys (2a) OR PEG-Intron (2b)"[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown † Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon alfa-2a;   Drug: Placebo and peginterferon
2 Not yet recruiting Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a
3 Unknown † Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks);   Drug: Peginterferon (Pegasys) (96 weeks);   Drug: Peginterferon (Pegasys) (48 weeks)
4 Completed Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV
Condition: HIV Infections
Interventions: Drug: Peginterferon alfa-2a, Ribavirin, epoetin-β;   Drug: Peginterferon alfa-2a + Ribavirin for 12 weeks
5 Active, not recruiting A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa 2a
6 Completed A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Device: autoinjector;   Device: pre-filled syringe
7 Terminated
Has Results 		Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)
Condition: Hepatitis B
Interventions: Drug: Telbivudine (LdT);   Drug: peginterferon alpha-2a
8 Completed
Has Results 		Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir;   Other: Placebo;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin
9 Completed Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Hepatitis C
Interventions: Drug: MP-424;   Drug: Ribavirin;   Drug: Peginterferon Alfa-2b
10 Recruiting 100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)
Conditions: Sustained Virologic Response;   IL28B Polymorphism
Interventions: Drug: peginterferon alfa 2a (pegasys);   Drug: peginterferon alfa-2a (pegasys)
11 Recruiting Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load
Condition: Chronic Hepatitis B
Intervention: Drug: Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
12 Terminated PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: PEG-interferon alfa-2b;   Drug: PEG-interferon alfa-2b
13 Unknown † Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Drug: Placebo;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin
14 Terminated Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders
Condition: Hepatitis C, Chronic
Interventions: Drug: peg-interferon alfa-2b;   Drug: ribavirin;   Drug: amantadine
15 Completed A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
Conditions: Liver Cirrhosis;   Chronic Hepatitis C
Interventions: Drug: peginterferon alfa-2a 180μg;   Drug: peginterferon alfa-2a 90μg;   Drug: ribavirin
16 Recruiting PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
Condition: Chronic Hepatitis C
Intervention: Drug: Peginterferon alfa-2a and Ribavirin
17 Unknown † PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: PEG-interferon alfa-2b;   Drug: sorafenib tosylate;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
18 Not yet recruiting Study Comparing BMS-790052 (Daclatasvir) to Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Untreated Hepatitis C Patients
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: Telaprevir;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
19 Unknown † Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
20 Recruiting Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Condition: Hepatitis C Virus
Interventions: Drug: BMS-790052 (HCV NS5A Replication Co-factor Inhibitor);   Drug: BMS-650032 (HCV NS3 Protease Inhibitor);   Drug: Peginterferon alfa-2a;   Drug: Ribavirin

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services